TNDM

$24.82+0.19 (+0.77%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Tandem Diabetes Care, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$24.82
Potential Upside
5%
Whystock Fair Value$26.06
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi i...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.70B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.67
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-132.40%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.02

Recent News

StockStory
Mar 19, 2026

3 Reasons to Sell TNDM and 1 Stock to Buy Instead

The past six months have been a windfall for Tandem Diabetes’s shareholders. The company’s stock price has jumped 93.6%, hitting $24.34 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
The Fly
Mar 19, 2026

Micron downgraded, Five Below upgraded: Wall Street's top analyst calls

Micron downgraded, Five Below upgraded: Wall Street's top analyst calls

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 18, 2026

Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength?

Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 17, 2026

Why Are Tandem Diabetes (TNDM) Shares Soaring Today

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 7.8% in the afternoon session after investment firm Piper Sandler upgraded the stock to Overweight from Neutral and increased its price target.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
The Fly
Mar 17, 2026

DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls

DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.